New therapies for reducing post-myocardial left ventricular remodeling

Annals of Translational Medicine

Volumn 3, Issue 2, 2015, Pages

  Kloner, Robert A ^a,b   Shi, Jianru ^a   Dai, Wangde ^a  

^a HUNTINGTON MEDICAL RESEARCH INSTITUTES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85015487918     PISSN: 23055839     EISSN: 23055847     Source Type: Journal    
DOI: 10.3978/j.issn.2305-5839.2015.01.13     Document Type: Editorial

References (19)

1. Pedersen F, Butrymovich V, Kelbæk H, et al. Short-and Long-Term Cause of Death in Patients Treated With Primary PCI for STEMI. J Am Coll Cardiol 2014;64:2101-8.
2. Hochman JS, Bulkley BH. Expansion of acute myocardial infarction: an experimental study. Circulation 1982;65:1446-50.
3. Eaton LW, Weiss JL, Bulkley BH, et al. Regional cardiac dilatation after acute myocardial infarction: recognition by two-dimensional echocardiography. N Engl J Med 1979;300:57-62.
4. Kloner RA, Leor J, Birnbaum Y. Remodeling, hibernation, and stunning. In: Poole-Wilson PA, Colucci WS, Massie BM, et al. eds. Heart Failure. New York: Churchill Livingstone, 1997:109-125.
5. Pfeffer MA, Braunwald E, Moyé LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 1992;327:669-77.
6. Müller-Ehmsen J, Peterson KL, Kedes L, et al. Rebuilding a damaged heart: long-term survival of transplanted neonatal rat cardiomyocytes after myocardial infarction and effect on cardiac function. Circulation 2002;105:1720-6.
7. Yao M, Dieterle T, Hale SL, et al. Long-term outcome of fetal cell transplantation on postinfarction ventricular remodeling and function. J Mol Cell Cardiol 2003;35:661-70.
8. Kearns-Jonker M, Dai W, Gunthart M, et al. Genetically Engineered Mesenchymal Stem Cells Influence Gene Expression in Donor Cardiomyocytes and the Recipient Heart. J Stem Cell Res Ther 2012;S1.pii: 005.
9. Dai W, Hale SL, Martin BJ, et al. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short-and long-term effects. Circulation 2005;112:214-23.
10. Dai W, Hale SL, Kloner RA. Role of a paracrine action of mesenchymal stem cells in the improvement of left ventricular function after coronary artery occlusion in rats. Regen Med 2007;2:63-8.
11. Smit NW, Coronel R. Stem cells can form gap junctions with cardiac myocytes and exert pro-arrhythmic effects. Front Physiol 2014;5:419.
12. Liu B, Duan CY, Luo CF, et al. Effectiveness and safety of selected bone marrow stem cells on left ventricular function in patients with acute myocardial infarction: A meta-analysis of randomized controlled trials. Int J Cardiol 2014;177:764-70.
13. Dai W, Kay GL, Jyrala AJ, et al. Experience from experimental cell transplantation therapy of myocardial infarction: what have we learned? Cell Transplant 2013;22:563-8.
14. Reffelmann T, Kloner RA. Intracoronary blood-or bone marrow-derived cell transplantation in patients with ischemic heart disease. Regen Med 2009;4:709-19.
15. Dai W, Kay GL, Kloner RA. The Therapeutic Effect of Cell Transplantation Versus Noncellular Biomaterial Implantation on Cardiac Structure and Function Following Myocardial Infarction. J Cardiovasc Pharmacol Ther 2014;19:350-7.
16. Frey N, Linke A, Süselbeck T, et al. Intracoronary Delivery of Injectable Bioabsorbable Scaffold (IK-5001) to Treat Left Ventricular Remodeling After ST-Elevation Myocardial Infarction: A First-in-Man Study. Circ Cardiovasc Interv 2014;7:806-12.
17. Dai W, Shi J, Gupta RC, et al. Bendavia, a Mitochondria-targeting Peptide, Improves Postinfarction Cardiac Function, Prevents Adverse Left Ventricular Remodeling, and Restores Mitochondria-related Gene Expression in Rats. J Cardiovasc Pharmacol 2014;64:543-53.
18. Dai W, Herring MJ, Hale SL, et al. Abstract 158: Transient Hypothermia During the Acute Phase of Myocardial Infarction Dramatically Reduces Scar Size, Prevents Left Ventricular Dilation and Remodeling, and Preserves Cardiac Function. American Heart Association Resuscitation Science Symposium (ReSS), November 15-16, 2014 held in Chicago, IL.
19. Eckhouse SR, Purcell BP, McGarvey JR, et al. Local hydrogel release of recombinant TIMP-3 attenuates adverse left ventricular remodeling after experimental myocardial infarction. Sci Transl Med 2014;6:223ra21.